# ASCO Guidelines vs HemeOncBuddy

The clearest difference is review sentiment: HemeOncBuddy at 100% against ASCO Guidelines's 57%. HemeOncBuddy also leads on rating (5.0 vs 4.8). ASCO Guidelines's advantage is update cadence (every 5 months vs every 24 months) and ratings volume (259 vs 18). On price, ads, in-app purchases and monetization model there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

HemeOncBuddy holds the better App Store score, 5.0 against 4.8. That said, the two scores are not equally well evidenced: ASCO Guidelines has 259 ratings behind it against 18, so its average is the more settled of the two. Written reviews point the same way: 57% of ASCO Guidelines's written reviews are positive against 100% of HemeOncBuddy's.

ASCO Guidelines ships an update every 5 months, HemeOncBuddy every 24 months. Both last shipped on October 24, 2026.

## The numbers

| Metric | ASCO Guidelines | HemeOncBuddy |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [4.8 (259 ratings)](https://appshunter.io/ios/app/asco-guidelines/id1238827183/reviews) | **[5.0 (18 ratings)](https://appshunter.io/ios/app/hemeoncbuddy/id1579207336/reviews)** |
| Number of ratings | **259** | 18 |
| Positive reviews | 57.1% of reviews | **100.0% of reviews** |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | **Every 5 months** | Every 24 months |
| Monetization | Free | Free |
| Size | 411 MB | 16 MB |
| Requires iOS | **10.0** | 15.0 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 12+ | 17+ |
| Developer | [American Society of Clinical Oncology](https://appshunter.io/developer/1513043539) | [Veli Bakalov](https://appshunter.io/developer/1579207338) |

## What reviewers say

### ASCO Guidelines

[App page](https://appshunter.io/ios/app/asco-guidelines/id1238827183)

Access comprehensive cancer care guidelines and interactive tools to inform treatment decisions. This app supports healthcare providers, patients, and caregivers in implementing recommended cancer care options for various cancer types, aiming to improve the quality of care.

**Highlights:** Guideline recommendations for cancer care, Interactive treatment decision tools, Supports healthcare providers, Informs patients and caregivers, Covers various cancer types, Regularly updated content

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### HemeOncBuddy

[App page](https://appshunter.io/ios/app/hemeoncbuddy/id1579207336)

This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.

**Highlights:** Practice-changing clinical trial summaries, Hematology and Oncology focus, Simplified trial information, Inclusion and exclusion criteria, Primary endpoints and outcomes, Quick reference tool

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is ASCO Guidelines free?

ASCO Guidelines is free to download, with no in-app purchases.

### Is HemeOncBuddy free?

HemeOncBuddy is free to download, with no in-app purchases.

### Which has better reviews, ASCO Guidelines or HemeOncBuddy?

HemeOncBuddy is rated higher. ASCO Guidelines averages 4.8 out of 5 from 259 ratings, while HemeOncBuddy averages 5.0 from 18 ratings.

### Do ASCO Guidelines or HemeOncBuddy have ads?

Neither ASCO Guidelines nor HemeOncBuddy shows ads.

### Which is updated more often, ASCO Guidelines or HemeOncBuddy?

ASCO Guidelines ships an update every 5 months, and HemeOncBuddy every 24 months. Most recently, ASCO Guidelines was updated on October 24, 2026 and HemeOncBuddy on October 24, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*